血液透析患者胃癌手术预后:多中心回顾性研究
该多中心回顾性研究纳入9家机构75例接受胃癌手术的血液透析患者,发现I期占58.7%,总体并发症率25.3%,30天死亡率1.3%。pStage I-IV的5年总生存率分别为59.2%、42.9%、32.3%、0%,非胃癌相关死亡占40.0%,早期患者中尤为突出。高龄、透析>5年、全胃切除和pStage IV是总生存差的独立预测因素;高龄、透析>5年及心血管病是非胃癌相关死亡的独立预测因素。
要点
- 透析胃癌患者早期阶段占比高,但非胃癌相关死亡风险显著。
- pStage I-IV的5年总生存率分别为59.2%、42.9%、32.3%、0%。
- 高龄、透析>5年、全胃切除和pStage IV预测总生存差。
核心结论
- 血液透析胃癌患者术后生存结局差,尤其早期患者主要死于非胃癌原因。
- 术前合并症和透析特征有助于预测该脆弱人群的长期结局。
研究设计与样本
- 多中心回顾性研究,来自9家机构,纳入75例接受胃癌手术的血液透析患者。
- 采用多变量Cox风险模型确定总生存差和非胃癌相关死亡的独立预测因素。
主要发现
- I期疾病占58.7%,总体并发症率25.3%,30天死亡率1.3%。
- pStage I、II、III、IV的5年总生存率分别为59.2%、42.9%、32.3%、0%。
- 14.7%患者死于胃癌,40.0%死于非胃癌原因;非胃癌相关死亡在pStage I(95.2%)和II(75.0%)中尤为普遍。
- 高龄、透析>5年、全胃切除和pStage IV是总生存差的独立预测因素。
- 高龄、透析>5年及心血管病是非胃癌相关死亡的独立预测因素;三者均有的患者3年总生存率仅14.3%。
临床怎么用
- 术前应评估高龄、透析时长和心血管合并症,以识别非胃癌死亡高风险患者。
- 对早期透析胃癌患者,需权衡手术获益与非胃癌死亡风险,加强围术期管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about the survival outcomes of and predictive factors for survival in hemodialysis patients undergoing surgery for gastric cancer. METHODS: We performed a multicenter retrospective study from 9 institutions to investigate the survival outcomes of 75 hemodialysis patients with gastric cancer. Patient characteristics included demographic data, hemodialysis- and gastric cancer-related variables. Multivariate Cox hazards models were applied to determine independent predictors of poor overall survival and non-gastric cancer related death. RESULTS: Stage I disease was predominant (58.7%) in our series. The overall morbidity and the 30-day mortality rates were 25.3% and 1.3%, respectively. The 5-year overall survival rates of patients with pStages I, II, III, and IV disease were 59.2%, 42.9%, 32.3%, and 0%, respectively. Eleven (14.7%) patients died of gastric cancer, whereas many more (40.0%) died owing to causes other than gastric cancer. Non-gastric cancer-related death was especially prevalent in patients with pStages I (95.2%) and II (75.0%) disease. Multivariable analysis revealed advanced age, long duration of hemodialysis (> 5 years), total gastrectomy, and pStage IV disease to be independently associated with poor overall survival. Notably, advanced age, long duration of hemodialysis, and the presence of cardiovascular disease were all independent predictors of non-gastric cancer-related death. Patients with all 3 factors had very poor survival outcomes (3-year overall survival; 14.3%). CONCLUSION: The survival outcomes of hemodialysis patients with gastric cancer, especially those with early-stage gastric cancer, were clearly poor, largely owing to the increased risk of non-gastric cancer-related death. Preoperative comorbidities and hemodialytic features were useful for predicting long-term outcomes of this vulnerable population.
引用
- Sugawara K, Yamashita H, Yajima S, et al. Prognosis of hemodialysis patients undergoing surgery for gastric cancer: Results of a multicenter retrospective study. Surgery. 2021. PMID: 33632543. doi:10.1016/j.surg.2021.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。